HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.
about
Controlling the HIV/AIDS epidemic: current status and global challengesHIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.Aggressive extranodal peripheral T-cell non-Hodgkin's lymphoma: A rare case report and review.Immune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaHIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.Direct phenotypical and functional dysregulation of primary human B cells by human immunodeficiency virus (HIV) type 1 in vitro.The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient miceAIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral TherapyEffect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma.Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).Immune regulation and evasion of Mammalian host cell immunity during viral infection.Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental deathTLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosisEpstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.Short communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom.Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.HIV-associated large aggressive extranodal lymphoma of the oral cavity.HIV/AIDS: 30 years of progress and future challenges.The role of microRNAs in the pathogenesis of HIV-related lymphomas.A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.Role of microRNAs in primary central nervous system lymphomas.Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.
P2860
Q30420558-422518D1-0F62-46D5-BAD2-58E9BEA03ED2Q33598231-59A59D55-BDFA-4D8A-9045-2093606A0A41Q33767818-7CDAD84E-FDBB-457F-BF46-B3CC894EE343Q33785791-9CEB9C17-B24B-4693-A8C3-BD740A290A63Q33887336-10377124-5FD4-4273-B086-D61FF61D6E65Q34049757-D3182176-2AFA-44B5-8F85-76AFE1E396FBQ34321247-4491C473-93B0-48C7-A5AF-DDCEA7FCEC04Q34328961-39FB33DF-6706-4E66-9980-23C53096932EQ35227197-578CC9C7-D23A-462A-B859-C46F4DB93F14Q35779619-65FAB61C-CB06-47C4-BBBB-A006D1DB6694Q35878906-0DA558FD-A1AF-4FCC-91A0-54336ED4006DQ35961549-4A197082-D3DF-49CA-8AF6-166C04AAE553Q36306025-BCA60A59-6287-4A41-97C4-165D432DD65CQ36456970-39E2616E-0C69-4F5A-BE0C-FF97AE40AFE6Q36471585-10C3E5C2-6176-49A8-A41B-527DB1909C71Q36832077-92784B4F-7A66-433B-A469-70910091E3A0Q36956948-0E8A9F36-575D-4375-8432-CDED5FDCB6F0Q37185126-C422F2AF-51FD-4ECF-9D38-FF9DA873FEBDQ37355725-1F989584-2A0F-43CA-BB79-E2504B0DBB76Q37355991-07464C7D-9C13-4074-834A-B5BF2984FA2EQ37359248-6B522AB7-C330-41F1-9ED0-04E2849D7A2AQ37580377-6E22BB8B-F74E-49F0-81EE-4FAE102F8EEEQ37627843-48210F55-0196-4323-A07D-9BF944DD5F95Q37710850-051600BA-83F4-4393-A447-04BD2405DA69Q37962420-F4C48627-8748-4FF3-ADB5-253A9DA80014Q38555990-B536C339-0675-4EE8-958F-95C352ADCA78Q38659232-C35117F3-8D38-4F29-94FB-97B41CCE0A56Q38779730-6A01BC04-7837-415A-BCEA-8A56BC90EB2BQ39367196-029D3FDE-BAD5-41A7-B37F-CD1020C38D8FQ44096163-8BEA7134-C209-4037-B961-18DAFF14AB88Q50101286-B354EBD6-B5ED-4101-A2BC-7E089F3B69ECQ51732134-27FA3002-4559-48D9-9D3B-1DFC55CEC511
P2860
HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@en
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@nl
type
label
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@en
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@nl
prefLabel
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@en
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@nl
P2860
P921
P1433
P1476
HIV-associated immune dysfunct ...... esis of AIDS-related lymphoma.
@en
P2093
Elena Vendrame
Marta Epeldegui
P2860
P2888
P356
10.1007/S12026-010-8168-8
P577
2010-12-01T00:00:00Z